Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
Vienna, Austria – 18 June 2017: The tenth year of data on cardiac arrhythmia treatment is being launched at EHRA EUROPACE - CARDIOSTIM 2017.
The edition marks the ten year anniversary of the European Heart Rhythm Association (EHRA) White Book, which reports on the current status of cardiac arrhythmia treatment and has been published yearly since 2008.1
Participation is open to the 56 national cardiac societies in Europe and the Mediterranean basin which make up the European Society of Cardiology (ESC) institutional membership. This year saw a record of voluntary contributions from 53 countries.
“The EHRA White Book is the only source of information for clinicians, health administrators and politicians on cardiac arrhythmia treatment in their own country and beyond,” said EHRA White Book Coordinator Professor Pekka Raatikainen, Head Physician, Helsinki University Hospital, Finland.
The EHRA White Book provides data on the use of cardiac implantable electronic devices (CIEDs) including pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronisation therapy (CRT) devices, and implantable loop recorders. Details are given on interventional electrophysiology procedures such as catheter ablation, left atrial appendage closure, and CIED lead extraction.
In addition, the EHRA White Book gives statistics about country demographics, healthcare funding and reimbursement of CIEDs and procedures, education and quality control in cardiac arrhythmias, and obstacles to implementing ESC Guidelines on ICD and pacemaker implantation.
The 2017 edition will enable clinicians, administrators and politicians in participating countries to view the contemporary picture of cardiac arrhythmia treatment at home and compare it with neighbouring countries. It also has the first two year data on implantation of subcutaneous ICDs and leadless pacemakers.
Professor Raatikainen said: “The data compilation shows that there are still important discrepancies between countries in the ESC area. The highest volumes of device implantations and interventional procedures are in the Western and Northern countries. Numbers are much lower in the non-European countries particularly but also in some countries in the Eastern ESC area – societies in these countries can use the figures to lobby their governments and health administrations for more resources.”
A ten-year comparative analysis of the EHRA White Book data from 2007 to 2016 will be published in an EP Europace supplement during ESC Congress in Barcelona, Spain.
Professor Raatikainen said: “The comparative analysis will show the evolution of treatment for cardiac arrhythmias and where improvements are needed.”
In addition to between-country comparisons, regional figures will be compiled for Northern, Southern, Eastern, Western and non-ESC countries. The top three and lowest three countries for volumes of each procedure will be listed. A website will be launched during ESC Congress that allows countries to directly compare their data with another country.
ESC Press OfficeTel: +33 (0) 4 89 87 34 83Email: firstname.lastname@example.org
SOURCES OF FUNDING: BIOTRONIK SE & Co. KG – in the form of an educational grant. DISCLOSURES: None.References and notes1 www.escardio.org/EHRA-whitebookAbout EHRA EUROPACE - CARDIOSTIM EHRA EUROPACE - CARDIOSTIM is an established, international conference attracting key opinion leaders, well-recognised scientists, physicians, allied professionals and industry.About the European Heart Rhythm AssociationThe European Heart Rhythm Association (EHRA) is a registered branch of the European Society of Cardiology (ESC). Its aim is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death. EHRA ensures the dissemination of knowledge and standard setting; provides continuous education, training and certification to physicians and allied professionals involved in the field of cardiac arrhythmias with a special focus on Atrial Fibrillation (AF) and Electrophysiology (EP). EHRA releases international consensus documents and position papers, it is a source of high quality, unbiased, evidence based, scientific information that promotes the quality of care for patients with AF, and for, has also dedicated a website for patients “afibmatters.org”. About the European Society of CardiologyThe European Society of Cardiology brings together health care professionals from more than 140 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.Information for journalists attending EHRA EUROPACE - CARDIOSTIM 2017EHRA EUROPACE - CARDIOSTIM 2017 takes place 18 to 21 June in Vienna, Austria, at the Reed Messe Wien GmbH. The full scientific programme is available here
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved